Skip to content

Author

H. Bwanika

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Multi-omics profiling identifies triciribine as a biomarker-guided antimetabolite therapy for acute lymphoblastic leukemia

Acute lymphoblastic leukemia (ALL) exhibits molecular and metabolic heterogeneity that limits therapeutic efficacy. Although antimetabolites remain central to ALL treatment, determinants of therapeutic sensitivity and resistance remain incompletely understood. Here, we investigated the activity and molecular response l...

Xue-Kang Qi, G. Mermelekas, Ondřej Hodek et al. · 0 citations
Open access Jul 2026

Model-guided discovery of MTOR-oriented synergistic drug combinations in colorectal cancer

Colorectal cancer (CRC) exhibits high genetic heterogeneity and frequent resistance to single-agent therapies, highlighting the need for rationally designed drug combinations. We apply a mechanistic modelling framework to prioritise synergistic combinations in 16 CRC cell lines. Simulations of 210 double perturbation...

Viviam Solangeli Bermúdez Paiva, H. Bwanika, M.S. Sigfúsdóttir et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.